Sex differences in the case-fatality rates for COVID-19—A comparison of the age-related differences and consistency over seven countries
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Background: Early in the COVID-19 pandemic, it was noted that males seemed to have higher case-fatality rates than females. We examined the magnitude and consistency of the sex differences in age-specific case-fatality rates (CFRs) in seven countries. Methods: Data on the cases and deaths from COVID-19, by sex and age group, were extracted from the national official agencies from Denmark, England, Israel, Italy, Spain, Canada and Mexico. Age-specific CFRs were computed for males and females separately. The ratio of the male to female CFRs were computed and meta-analytic methods were used to obtained pooled estimates of the male to female ratio of the CFRs over the seven countries, for all age-groups. Meta-regression and sensitivity analysis were conducted to evaluate the age and country contribution to differences. Results: The CFRs were consistently higher in males at all ages. The pooled M:F CFR ratios were 1.71, 1.88, 2.11, 2.11, 1.84, 1.78 and 1.49, for ages 20–29, 30–39, 40–49, 50–59, 60–69, 70–79, 80+ respectively. In meta-regression, age group and country were associated with the heterogeneity in the CFR ratios. Conclusions: The sex differences in the age-specific CFRs are intriguing. Sex differences in the incidence and mortality have been found in many infectious diseases. For COVID-19, factors such as sex differences in the prevalence of underlying diseases may play a part in the CFR differences. However, the consistently greater case-fatality rates in males at all ages suggests that sex-related factors impact on the natural history of the disease. This could provide important clues as to the mechanisms underlying the severity of COVID-19 in some patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For COVID-19, the CFR was higher for men than for women.122”
From Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review (2025) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“1, and/or I(2)�50%, the random effects model [23] was used to estimate pooled CFRRs and 95% confidence intervals (CI).”
MethodCollaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,219
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.021 · Cited by 2,074
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
Gender differences in the utilization of health care services.
Bertakis, K. D., Azari, R. S., Helms, L., Callahan, E. J., & Robbins, J. A. (2000) · PubMed · Cited by 1,464
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Hu, S., Marshall, C., Darby, J., Wei, W., Lyons, A. B., & Körner, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00001 · Cited by 973
Research works printed but not linked: 3
- A Dictionary of Epidemiology. Edited by Miquel Porta. Oxford University Press. 6th Edition. 2014.
- S Ravi, 2020, COVID-19 trends from Germany show different impacts by gender and age
- A Gupta-Wright, 2019, Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial, Clin Infect Dis, ciz1133
Cited by
Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine
Green, M. S., Peer, V., Magid, A., HaGani, N., Anis, E., & Nitzan, D. (2022) · Vaccines · doi:10.3390/vaccines10020233 · Cited by 118
Self-citationSex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Lott, N., Gebhard, C. E., Bengs, S., Haider, A., Kuster, G. M., Regitz‐Zagrosek, V., & Gebhard, C. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00780-6 · Cited by 43
Esmaeili, E. D., Fakhari, A., Naghili, B., Khodamoradi, F., & Azizi, H. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27594 · Cited by 27
Malani, A., & Ramachandran, S. (2022) · Journal of Development Economics · doi:10.1016/j.jdeveco.2022.102988 · Cited by 24
Study of Post-COVID-19 Syndrome in Saudi Arabia
Mahmoud, M. H., Alghamdi, F. A., Alghamdi, G. A., Alkhotani, L. A., Alrehaili, M. A. M., & Eldeeb, D. (2021) · Cureus · doi:10.7759/cureus.17787 · Cited by 24
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
Menezes, A. M. B., Victora, C. G., Hartwig, F. P., da Silveira, M. F., Horta, B. L., Barros, A. J. D., Mesenburg, M. A., Wehrmeister, F. C., Pellanda, L. C., Dellagostin, O. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92775-y · Cited by 22
Tsaturyan, V. V., Manvelyan, A., Balayan, M. H., Harutyunyan, N., Pepoyan, E. S., Torok, T., Chikindas, M. L., & Pepoyan, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1107485 · Cited by 18
Testosterone and estradiol reduce inflammation of human macrophages induced by anti‐SARS‐CoV‐2 IgG
Allahverdiyeva, S., Geyer, C. E., Veth, J., de Vries, L. M., de Taeye, S. W., van Gils, M. J., den Dunnen, J., & Chen, H. (2024) · European Journal of Immunology · doi:10.1002/eji.202451226 · Cited by 15
Aklil, M. B., Temesgan, W. Z., Gessesse, D. N., Kassa, B. G., Tiguh, A. E., Kebede, A. A., Demelash, M., & Yismaw, A. E. (2022) · Frontiers in Education · doi:10.3389/feduc.2022.799301 · Cited by 13
Biological sex and age-related differences shape the antiviral response to SARS-CoV-2 infection
Mendoza, V. M. M., Cortina, Y. A. M., Rodríguez-Perea, A. L., Fernández, G. J., Rugeles, M. T., Hernandez, P. A. V., & Maya, W. D. C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13045 · Cited by 13
Griffin, I. S., King, J., Lyons, B. C., Singleton, A. L., Deng, X., Bruce, B. B., & Griffin, P. M. (2024) · Emerging infectious diseases · doi:10.3201/eid3006.231285 · Cited by 11
Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology
Lemarchand, P., Pape, M., & Schwarz, J. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00762-z · Cited by 12
Using Household Rosters from Survey Data to Estimate All-cause Mortality during COVID in India
Malani, A., & Ramachandran, S. (2021) · National Bureau of Economic Research · doi:10.3386/w29192 · Cited by 11
Huang, J., Ma, X., Wu, H., Awuxi, H., Zhang, X., Chen, Y., NIGEDELI, A., & Li, Q. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10654-7 · Cited by 8
Attention to COVID 19 pandemic resulted in increased measles cases and deaths in Zambia
Mwangilwa, K., Sialubanje, C., Chipoya, M., Mulenga, C., Mwale, M., Chileshe, C., Sinyange, D., Banda, M., Gardner, P. N., Lamba, L., et al. (2025) · Tropical Medicine and Health · doi:10.1186/s41182-025-00736-2 · Cited by 8
Was Alpha deadlier than wild-type COVID? Analysis in rural England
Brainard, J. S., Sampedro, C. M. G., Sweeting, A., & Fordham, R. J. (2022) · Infection · doi:10.1007/s15010-022-01787-x · Cited by 9
McDougal, L., Dehingia, N., Cheung, W. W., Dixit, A., & Raj, A. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101606 · Cited by 9
Mavragani, C. P., Skarlis, C., Kostopoulos, I. V., Maratou, E., Moutsatsou, P., Terpos, E., Tsitsilonis, O., Dimopoulos, M. A., & Sfikakis, P. P. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155964 · Cited by 7
Cardenas, E. P. V., Triana, A. J., Mendoza, H., Buendía, E., & Viasus, D. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13707 · Cited by 8
Are COVID-19 Case Fatality Rates a Reliable Measure of Sex Disparities?
Gompers, A. D., Bruch, J. D., & Richardson, S. S. (2021) · Women s Health Issues · doi:10.1016/j.whi.2021.11.007 · Cited by 7
Morgenstern, C., Rawson, T., Routledge, I., Kont, M., Imai-Eaton, N., Skarp, J., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101144 · Cited by 6
Mehta, C. C., Hagen, K. S., Rubtsova, A., Lahiri, C. D., Michopoulos, V., Moran, C. A., Haddad, L. B., Titanji, K., Collins, L. F., Quyyumi, A. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272608 · Cited by 7
Recalibrating healthcare to create a more equitable post-pandemic work environment
Pyle, W. G., & Roesch, F. C. (2021) · Healthcare Management Forum · doi:10.1177/08404704211054142 · Cited by 9
Wetchayont, P., & Waiyasusri, K. (2021) · GEOGRAPHY ENVIRONMENT SUSTAINABILITY · doi:10.24057/2071-9388-2021-090 · Cited by 6
Green, M. S., Schwartz, N., & Peer, V. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287008 · Cited by 5
Self-citationMortality and case fatality rates of covid-19 in the state of goiás, brazil
Trivilato, R. A., Morais, T. C., Daboin, B. E. G., Cavalcanti, M. P. E., Jacintho, L. C., Raimundo, R. D., Eichemberg, J. D. O., Elmusharaf, K., Siqueira, C. E., & de Figueiredo, J. L. (2021) · Journal of Human Growth and Development · doi:10.36311/jhgd.v31.12781 · Cited by 8
Sex differences in response to COVID-19 mRNA vaccines in Italian population
Ferroni, E., Mateo‐Urdiales, A., Bietta, C., Cesaroni, G., Anticoli, S., Maggio, E. D., Ancona, A., Petrone, D., Cannone, A., Sacco, C., et al. (2024) · Epidemiology and Infection · doi:10.1017/s0950268824001079 · Cited by 6
Riad, A., Alsaad, S. S., Almurikhi, A. A., Alzahrani, F. A. A., Alghamdi, A. M., Alzaid, E. H., & Klugar, M. (2022) · Vaccines · doi:10.3390/vaccines10122137 · Cited by 4
Zou, P., Heath, A., Sewell, C. A., Lu, Y., Tran, D. C., & Seo, S. K. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2508 · Cited by 4
Yohann, A., Mulima, G., Kayange, L., Purcell, L. N., Gallaher, J. R., & Charles, A. G. (2023) · World Journal of Surgery · doi:10.1007/s00268-023-06896-8 · Cited by 4
Sex differences in coronavirus disease 2019 myocarditis
Beetler, D. J., & Fairweather, D. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100704 · Cited by 3
Liu, V. Y., Godfrey, M., Dunn, M. G., Fowler, R., Guthrie, L., Dredge, D. C., Holmes, S., Johnston, A. M., Simoneau, T., Fasano, A., et al. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1484941 · Cited by 3
Kaim, A., Shetrit, S. B., & Saban, M. (2022) · Healthcare · doi:10.3390/healthcare10122355 · Cited by 5
Impact of COVID-19 on Spanish mortality rates in 2020 by age and sex
Navarro, E., & Requena, P. (2023) · Journal of Public Health · doi:10.1093/pubmed/fdad023 · Cited by 6
Morgenstern, C., Rawson, T., Routledge, I., Kont, M. D., Imai, N., Skarp, J. E., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., et al. (2024) · medRxiv · doi:10.1101/2024.08.13.24311934 · Cited by 3
The vaccination characteristics and mortal causes analysis of COVID-19 deaths at a district level
Yavuz, M., & Sezerol, M. A. (2023) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1255788 · Cited by 3
Ballering, A., Oertelt‐Prigione, S., Hartman, T. O., & Rosmalen, J. G. M. (2022) · Journal of Women s Health · doi:10.1089/jwh.2022.0157 · Cited by 2
Mitura, K. M., Celiński, D., Bielan, O., Snarska, J., & Szajda, S. D. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1747666 · Cited by 1
Gender Impact Assessment of the COVID-19 Pandemic in Ukraine
Ivanov, I. L., & Александрович, Б. И. (2023) · Lecture notes in networks and systems · doi:10.1007/978-3-031-30251-0_5 · Cited by 1
More on age and gender in COVID-19
Ferretti, V. V., Klersy, C., Bruno, R., Cutti, S., & Nappi, R. E. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.05.011 · Cited by 1
Navarro, E., & Requena, P. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4063837 · Cited by 1
Ekonomski fakultet Sveučilišta u Zagrebu, Z., & Smolić, Š. (2021) · Migracijske i etničke teme / Migration and Ethnic Themes · doi:10.11567/met.37.2.1
(2022) · Medical & Clinical Research · doi:10.33140/mcr.07.036
COVID-19 Lethality: Insights from Case Fatality Rate
Sreedharan, J. (2023) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2023.18.002513
Epidemiological Characteristics of COVID-19 Patients in Mazandaran, Iran, 2021
Shabestan, R., Amani, B., Amani, B., Khorramnia, S., Zareei, S., Parsaee, M., Kianian, H., charkameh, A., & Akbarzadeh, A. (2023) · Journal of Occupational Health and Epidemiology · doi:10.61186/johe.12.1.18
Twists and turns: Sex and gender differences in the illness trajectories of common somatic symptoms
Ballering, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.902736104
Short-term side effects of BNT162b2 vaccine in primary care settings in Qatar: a retrospective study
Abdeen, S., Alah, M. A., Zaidan, M., Ibrahim, M. I. M., Abdulmajeed, J., Al-Nuaimi, A. A., & Al‐Kuwari, M. G. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1384327
Bates, L. M. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780197625217.003.0007
Nadmiarowe zgony podczas pandemii COVID-19 w Polsce i ocena skuteczności szczepień
Kochański, B., & Sochacki, J. (2024) · Wiadomości Statystyczne The Polish Statistician · doi:10.59139/ws.2024.05.3 · Cited by 1
Jafari, R., Javanbakht, M., Ardebili, M. H. A., Ghazale, A. H., Jafari, A., & Saburi, A. (2025) · Imaging · doi:10.1556/1647.2025.00301
González‐Parra, G., Luebben, G., Villanueva, R. J., Navarro-González, F. J., & Bhakta, B. (2025) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2025.10.015 · Cited by 1
Metadata
- Authors
- Green, M. S., Nitzan, D., Schwartz, N., Niv, Y., & Peer, V.
- Affiliations
- University of Haifa (IL)
- World Health Organization - Denmark (DK)
- Israel Ministry of Health (IL)
- Corresponding author
- Green, Manfred S.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-29
- Volume
- 16
- Issue
- 4
- Pages
- e0250523
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8084161
- OpenAlex
- W3157347494
- Cited by
- 52
- References
- 51
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 10 · 2023: 10 · 2022: 15 · 2021: 10
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Keywords
- COVID-19 pandemic, case fatality rate, sex differences, age-specific mortality, sex differences in disease severity, cross-national comparison, underlying disease
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Canada, Child, Child, Preschool, England, Europe, Female, Humans, Infant, Israel, Male, Mexico, Middle Aged, Retrospective Studies, Sex Factors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.